Gleevec Gets High Marks for Leukemia Treatment
New research suggests that Gleevec has transformed CML, a previously fatal leukemia, into a manageable chronic disease for many patients who take it.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.